Scientists have devised various pharmaceutical and non-pharmaceutical strategies to protect individuals from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Study: Remdesivir resistance in transplant recipients
Remdesivir resistance in renal transplant patients with long COVID-19
